Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and in the postoperative period: A cause for concern

Hepatology

Volumn 59, Issue 2, 2014, Pages 496-504

  Lee, Ser Yee ^a   Mooney, Michael A ^a   Inra, Matthew L ^a   Juluru, Krishna ^a   Fox, Alyson N ^a   Olsen, Sonja K ^a   Brown, Robert S ^b   Emond, Jean C ^b   Cherqui, Daniel ^a   Kluger, Michael D ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NewYork Presbyterian Columbia University Irving Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BIOLOGICAL ACTIVITY; CLINICAL EVALUATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; IMAGING SYSTEM; IONIZING RADIATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RADIATION EXPOSURE; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TREATMENT INDICATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIATION, IONIZING; RETROSPECTIVE STUDIES; RISK FACTORS; WAITING LISTS;

EID: 84893692536     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26633     Document Type: Article

References (51)

1. Saini S, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, et al. Liver lesion characterization. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(Suppl):193-199.
2. Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA 2012;307:2400-2409.
3. Barrett B, Stiles M, Patterson J. Radiation risks: critical analysis and commentary. Prev Med 2012;54:280-282.
4. Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009;169:2071-2077.
5. Berrington de Gonzalez A, Kutsenko A, Rajaraman P. Sarcoma risk after radiation exposure. Clin Sarcoma Res 2012;2:18.
6. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
7. Murray KF, Carithers RL, AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432.
8. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022.
9. Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl 2012;18:1277-1289.
10. Pawel DJ. U.S. Environmental Protection Agency radiogenic risk projections: uncertainty analysis. Health Phys 2013;104:26-40.
11. Wakeford R. Radiation effects: modulating factors and risk assessment - an overview. Ann ICRP 2012;41:98-107.
12. Wakeford R. The cancer epidemiology of radiation. Oncogene 2004;23:6404-6428.
13. Lazo E, Smith R, Coates R, Andersen R, Asano Y, Chapple CL, et al. The state of radiological protection; views of the radiation protection profession: IRPA13, Glasgow, May 2012. J Radiol Prot 2012;32:489-524.
14. Concejero AM, Yong CC, Chen CL, Lu HI, Wang CC, Wang SH, et al. Solitary pulmonary nodule in the liver transplant candidate: importance of diagnosis and treatment. Liver Transpl 2010;16:760-766.
15. Koneru B, Teperman LW, Manzarbeitia C, Facciuto M, Cho K, Reich D, et al. A multicenter evaluation of utility of chest computed tomography and bone scans in liver transplant candidates with stages I and II hepatoma. Ann Surg 2005;241:622-628.
16. Ali A, Bhardwaj HL, Heuman DM, Jovin IS. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management. Clin Transplant 2013;27:E207-E215.
17. Lyu J, Lee SG, Hwang S, Lee SO, Cho OH, Chae EJ, et al. Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates. Liver Transpl 2011;17:963-968.
18. Chae WY, Hwang S, Yoon YI, Kang MC, Moon DB, Song GW, et al. Clinical value of preoperative coronary risk assessment by computed tomographic arteriography prior to adult living donor liver transplantation. Transplant Proc 2012;44:415-417.
19. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:1707-1732.
20. Dawwas MF, Gimson AE. Candidate selection and organ allocation in liver transplantation. Semin Liver Dis 2009;29:40-52.
21. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008;57:252-257.
22. Castaing D, Salloum C, Azoulay D, Adam R, Vibert E, Veilhan LA, et al. Adult liver transplantation: the Paul Brousse experience. Clin Transpl 2007:145-154.
23. Kim SE, Lee HC, Kim KM, Lim YS, Chung YH, Lee YS, et al. Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center. Korean J Hepatol 2011;17:113-119.
24. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005;241:905-916; discussion 916-908.
25. Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. J Hepatobiliary Pancreat Sci 2010;17:548-554.
26. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284.
27. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008;248:254-263.
28. Huda W, Ogden KM, Khorasani MR. Converting dose-length product to effective dose at CT. Radiology 2008;248:995-1003.
29. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009;361:849-857.
30. Kobayashi J, Iwabuchi K, Miyagawa K, Sonoda E, Suzuki K, Takata M, et al. Current topics in DNA double-strand break repair. J Radiat Res 2008;49:93-103.
31. Balcer-Kubiczek EK. Apoptosis in radiation therapy: a double-edged sword. Exp Oncol 2012;34:277-285.
32. Saberi A, Salari E, Latifi SM. Cytogenetic analysis in lymphocytes from radiation workers exposed to low level of ionizing radiation in radiotherapy, CT-scan and angiogcardiography units. Mutat Res 2013;750:92-95.
33. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891-1901.
34. Campistol JM, Cuervas-Mons V, Manito N, Almenar L, Arias M, Casafont F, et al. New concepts and best practices for management of pre- and post-transplantation cancer. Transplant Rev (Orlando) 2012;26:261-279.
35. Herrero JI, Pardo F, D'Avola D, Alegre F, Rotellar F, Iñarrairaegui M, et al. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawal. Liver Transpl 2011;17:402-408.
36. Herrero JI, España A, D'Avola D, Pardo F, Iñarrairaegui M, Rotellar F, et al. Subsequent nonmelanoma skin cancer after liver transplantation. Transplant Proc 2012;44:1568-1570.
37. Gantt S, Casper C. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis 2011;24:295-301.
38. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005;80:S254-S264.
39. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59-67.
40. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144:27-40.
41. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009;458:719-724.
42. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996;2:426-430.
43. Williams K, Lewis JF, Davis G, Geiser EA. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation. Transplantation 2000;69:2354-2356.
44. Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, et al. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant 2012;26:E359-E364.
45. Liver EAFTSOT, Cancer EOFRATO. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
46. Decaens T. Liver transplantation for hepatocellular carcinoma: time for an international consensus. Clin Res Hepatol Gastroenterol 2012;36:316-318.
47. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003;38:1034-1042.
48. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104.
49. Di Martino M, De Filippis G, De Santis A, Geiger D, Del Monte M, Lombardo CV, et al. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. Eur Radiol 2013;23:887-896.
50. Senthilnathan S, Memon K, Lewandowski RJ, Kulik L, Mulcahy MF, Riaz A, et al. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology 2012;55:1432-1442.
51. Sheth H, Javed SS, Hilson AJ, Buscombe JR, Davidson BR. Radioisotope bone scans in the preoperative staging of hepatopancreatobiliary cancer. Br J Surg 2005;92:203-207.